Indira IVF Hospital abandons IPO plans, withdraws draft documents with SEBI

SEBI had received draft IPO papers on February 13, which were withdrawn on March 19, 2025, with the company not disclosing any reasons, according to an update on SEBI.

The issue size of Indira IVF, which is backed by investment firm EQT, was estimated to be around ₹3,500 crore and was exclusively an offer for sale.

Before this, hospitality OYO filed a DRHP via confidential mode in 2023 but later scrapped the IPO plans.

Tata Play, formerly Tata Sky, was India's first company to take the confidential filing route in December 2022. It also received SEBI's observation letter in April 2023 but did not move forward with the public issue.

According to experts, companies have no pressure to go for a share sale under the pre-filing route.

SEBI returns DRHP of Agriwarehousing

Meanwhile, the market regulator on March 19 returned preliminary IPO papers of tech-driven agricultural services provider Agriwarehousing and Collateral Management Ltd.

The company's proposed IPO consisted of a fresh issue of up to ₹450 crore and an offer for sale (OFS) of 2.69 crore shares by promoters and an investor.

As part of the OFS, Temasek Holdings' indirect subsidiary Claymore Investments (Mauritius) Pte had intended to offload 19 crore equity shares, and promoters were considering divesting 1.5 crore shares.